Anthony A. DiTonno
2019
In 2019, Anthony A. DiTonno earned a total compensation of $505.3K as Chief Executive Officer at Tenax Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $75,250 |
|---|---|
| Salary | $430,000 |
| Total | $505,250 |
DiTonno received $430K in salary, accounting for 85% of the total pay in 2019.
DiTonno also received $75.3K in non-equity incentive plan.
Rankings
In 2019, Anthony A. DiTonno's compensation ranked 11,736th out of 13,971 executives tracked by ExecPay. In other words, DiTonno earned more than 16.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,736 out of 13,971 | 16th |
Division Manufacturing | 4,755 out of 5,701 | 17th |
Major group Chemicals And Allied Products | 1,877 out of 2,200 | 15th |
Industry group Drugs | 1,618 out of 1,886 | 14th |
Industry Pharmaceutical Preparations | 1,200 out of 1,398 | 14th |
Source: SEC filing on April 29, 2020.
DiTonno's colleagues
We found one more compensation record of an executive who worked with Anthony A. DiTonno at Tenax Therapeutics in 2019.
2019
Michael Jebsen
Tenax Therapeutics